BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 28008149)

  • 1. Idelalisib induces PUMA-dependent apoptosis in colon cancer cells.
    Yang S; Zhu Z; Zhang X; Zhang N; Yao Z
    Oncotarget; 2017 Jan; 8(4):6102-6113. PubMed ID: 28008149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crizotinib induces PUMA-dependent apoptosis in colon cancer cells.
    Zheng X; He K; Zhang L; Yu J
    Mol Cancer Ther; 2013 May; 12(5):777-86. PubMed ID: 23427294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regorafenib inhibits colorectal tumor growth through PUMA-mediated apoptosis.
    Chen D; Wei L; Yu J; Zhang L
    Clin Cancer Res; 2014 Jul; 20(13):3472-84. PubMed ID: 24763611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cabozantinib induces PUMA-dependent apoptosis in colon cancer cells via AKT/GSK-3β/NF-κB signaling pathway.
    Yang S; Zhang X; Qu H; Qu B; Yin X; Zhao H
    Cancer Gene Ther; 2020 May; 27(5):368-377. PubMed ID: 31182761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pazopanib, a novel multi-kinase inhibitor, shows potent antitumor activity in colon cancer through PUMA-mediated apoptosis.
    Zhang L; Wang H; Li W; Zhong J; Yu R; Huang X; Wang H; Tan Z; Wang J; Zhang Y
    Oncotarget; 2017 Jan; 8(2):3289-3303. PubMed ID: 27924057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3β and NF-κB to suppress tumor cell growth.
    Dudgeon C; Peng R; Wang P; Sebastiani A; Yu J; Zhang L
    Oncogene; 2012 Nov; 31(46):4848-58. PubMed ID: 22286758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.
    Pereira DM; Simões AE; Gomes SE; Castro RE; Carvalho T; Rodrigues CM; Borralho PM
    Oncotarget; 2016 Jun; 7(23):34322-40. PubMed ID: 27144434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PUMA mediates the combinational therapy of 5-FU and NVP-BEZ235 in colon cancer.
    Wang H; Zhang L; Yang X; Jin Y; Pei S; Zhang D; Zhang H; Zhou B; Zhang Y; Lin D
    Oncotarget; 2015 Jun; 6(16):14385-98. PubMed ID: 25965911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aurora kinase inhibition induces PUMA via NF-κB to kill colon cancer cells.
    Sun J; Knickelbein K; He K; Chen D; Dudgeon C; Shu Y; Yu J; Zhang L
    Mol Cancer Ther; 2014 May; 13(5):1298-308. PubMed ID: 24563542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ipatasertib, a novel Akt inhibitor, induces transcription factor FoxO3a and NF-κB directly regulates PUMA-dependent apoptosis.
    Sun L; Huang Y; Liu Y; Zhao Y; He X; Zhang L; Wang F; Zhang Y
    Cell Death Dis; 2018 Sep; 9(9):911. PubMed ID: 30185800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idelalisib Impacts Cell Growth through Inhibiting Translation-Regulatory Mechanisms in Mantle Cell Lymphoma.
    Yang Q; Chen LS; Ha MJ; Do KA; Neelapu SS; Gandhi V
    Clin Cancer Res; 2017 Jan; 23(1):181-192. PubMed ID: 27342398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PUMA induction by FoxO3a mediates the anticancer activities of the broad-range kinase inhibitor UCN-01.
    Dudgeon C; Wang P; Sun X; Peng R; Sun Q; Yu J; Zhang L
    Mol Cancer Ther; 2010 Nov; 9(11):2893-902. PubMed ID: 20978166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NVP-BKM120 inhibits colon cancer growth via FoxO3a-dependent PUMA induction.
    Yang S; Li X; Guan W; Qian M; Yao Z; Yin X; Zhao H
    Oncotarget; 2017 Oct; 8(47):83052-83062. PubMed ID: 29137323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purified vitexin compound 1, a new neolignan isolated compound, promotes PUMA-dependent apoptosis in colorectal cancer.
    Chen J; Zhong J; Liu Y; Huang Y; Luo F; Zhou Y; Pan X; Cao S; Zhang L; Zhang Y; Wang J
    Cancer Med; 2018 Dec; 7(12):6158-6169. PubMed ID: 30402948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The multi-targeted kinase inhibitor sunitinib induces apoptosis in colon cancer cells via PUMA.
    Sun J; Sun Q; Brown MF; Dudgeon C; Chandler J; Xu X; Shu Y; Zhang L; Yu J
    PLoS One; 2012; 7(8):e43158. PubMed ID: 22912816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
    Ghosh JC; Altieri DC
    Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced TLR4 Expression on Colon Cancer Cells After Chemotherapy Promotes Cell Survival and Epithelial-Mesenchymal Transition Through Phosphorylation of GSK3β.
    Chung YH; Kim D
    Anticancer Res; 2016 Jul; 36(7):3383-94. PubMed ID: 27354597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The BH3-only protein, PUMA, is involved in oxaliplatin-induced apoptosis in colon cancer cells.
    Wang X; Li M; Wang J; Yeung CM; Zhang H; Kung HF; Jiang B; Lin MC
    Biochem Pharmacol; 2006 May; 71(11):1540-50. PubMed ID: 16595125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant p53 drives cancer chemotherapy resistance due to loss of function on activating transcription of PUMA.
    Huang Y; Liu N; Liu J; Liu Y; Zhang C; Long S; Luo G; Zhang L; Zhang Y
    Cell Cycle; 2019 Dec; 18(24):3442-3455. PubMed ID: 31726940
    [No Abstract]   [Full Text] [Related]  

  • 20. Augmented antitumor activity of 5-fluorouracil by double knockdown of MDM4 and MDM2 in colon and gastric cancer cells.
    Imanishi M; Yamamoto Y; Wang X; Sugaya A; Hirose M; Endo S; Natori Y; Yamato K; Hyodo I
    Cancer Sci; 2019 Feb; 110(2):639-649. PubMed ID: 30488540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.